In this study we explore the synergistic effect of PI3K inhibition in combination with other kinase inhibitors and drugs on merlin-deficient Schwann cells (MD-SCs) a model for specific for Neurofibromatosis type 2-associated schwannomas. The gene discussed is NF2; the disease is NF2-related schwannomatosis.